Cargando…

Dementia

Dementia is a clinical diagnosis requiring new functional dependence on the basis of progressive cognitive decline. It is estimated that 1.3% of the entire UK population, or 7.1% of those aged 65 or over, have dementia. Applying these to 2013 population estimates gives an estimated number of 19,765...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunningham, EL, McGuinness, B, Herron, B, Passmore, AP
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Ulster Medical Society 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488926/
https://www.ncbi.nlm.nih.gov/pubmed/26170481
_version_ 1782379254211674112
author Cunningham, EL
McGuinness, B
Herron, B
Passmore, AP
author_facet Cunningham, EL
McGuinness, B
Herron, B
Passmore, AP
author_sort Cunningham, EL
collection PubMed
description Dementia is a clinical diagnosis requiring new functional dependence on the basis of progressive cognitive decline. It is estimated that 1.3% of the entire UK population, or 7.1% of those aged 65 or over, have dementia. Applying these to 2013 population estimates gives an estimated number of 19,765 people living with dementia in Northern Ireland. The clinical syndrome of dementia can be due to a variety of underlying pathophysiological processes. The most common of these is Alzheimer's disease (50-75%) followed by vascular dementia (20%), dementia with Lewy bodies (5%) and frontotemporal lobar dementia (5%). The clinical symptoms and pathophysiological processes of these diseases overlap significantly. Biomarkers to aid diagnosis and prognosis are emerging. Acetylcholinesterase inhibitors and memantine are the only medications currently licensed for the treatment of dementia. The nature of symptoms mean people with dementia are more dependent and vulnerable, both socially and in terms of physical and mental health, presenting evolving challenges to society and to our healthcare systems.
format Online
Article
Text
id pubmed-4488926
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher The Ulster Medical Society
record_format MEDLINE/PubMed
spelling pubmed-44889262015-07-13 Dementia Cunningham, EL McGuinness, B Herron, B Passmore, AP Ulster Med J Review Dementia is a clinical diagnosis requiring new functional dependence on the basis of progressive cognitive decline. It is estimated that 1.3% of the entire UK population, or 7.1% of those aged 65 or over, have dementia. Applying these to 2013 population estimates gives an estimated number of 19,765 people living with dementia in Northern Ireland. The clinical syndrome of dementia can be due to a variety of underlying pathophysiological processes. The most common of these is Alzheimer's disease (50-75%) followed by vascular dementia (20%), dementia with Lewy bodies (5%) and frontotemporal lobar dementia (5%). The clinical symptoms and pathophysiological processes of these diseases overlap significantly. Biomarkers to aid diagnosis and prognosis are emerging. Acetylcholinesterase inhibitors and memantine are the only medications currently licensed for the treatment of dementia. The nature of symptoms mean people with dementia are more dependent and vulnerable, both socially and in terms of physical and mental health, presenting evolving challenges to society and to our healthcare systems. The Ulster Medical Society 2015-05 /pmc/articles/PMC4488926/ /pubmed/26170481 Text en © The Ulster Medical Society, 2015
spellingShingle Review
Cunningham, EL
McGuinness, B
Herron, B
Passmore, AP
Dementia
title Dementia
title_full Dementia
title_fullStr Dementia
title_full_unstemmed Dementia
title_short Dementia
title_sort dementia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488926/
https://www.ncbi.nlm.nih.gov/pubmed/26170481
work_keys_str_mv AT cunninghamel dementia
AT mcguinnessb dementia
AT herronb dementia
AT passmoreap dementia